{
    "Trade/Device Name(s)": [
        "Contour Next Control Solution"
    ],
    "Submitter Information": "Bayer Healthcare LLC",
    "510(k) Number": "K151742",
    "Predicate Device Reference 510(k) Number(s)": [
        "K111268"
    ],
    "Regulatory Class": "I, reserved",
    "Product Code(s)": [
        "JJX"
    ],
    "Summary Letter Date": "July 24, 2015",
    "Summary Letter Received Date": "July 27, 2015",
    "Submission Date": "September 3, 2015",
    "Regulation Number(s)": [
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Quality Control Material (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [],
    "Specimen Container(s)": [
        "2.5mL plastic bottle with applicator tip"
    ],
    "Instrument(s)/Platform(s)": [
        "Contour Next Blood Glucose Monitoring System"
    ],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "Control",
        "Quality control material"
    ],
    "Document Summary": "FDA 510(k) summary for Contour Next Control Solution as quality control material for Contour Next Blood Glucose Monitoring Systems",
    "Indications for Use Summary": "Aqueous glucose solutions intended for use in self-testing by people with diabetes as a quality control check to ensure Contour Next Blood Glucose Monitoring Systems are working properly",
    "fda_folder": "Clinical Chemistry"
}